HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report.

AbstractINTRODUCTION:
We describe a case of conservatively treated endometrial endometrioid (EE) adenocarcinoma which showed an aggressive clinical outcome after pregnancy.
CASE:
A 30-year-old woman with a well differentiated EE adenocarcinoma decided to attempt a conservative approach and underwent progestin treatment with subsequent negative ultrasound and hysteroscopic controls. After 3 months, she conceived and at 36 weeks of gestation, a cesarean section was performed with multiple negative biopsies. Eight 8 months after delivery, an exploratory laparotomy documented disseminated poorly differentiated EE adenocarcinoma. Staging work up revealed diffuse metastatic disease. Despite chemotherapy, the patient experienced progression of disease with fatal acute respiratory syndrome due to massive neoplastic pulmonary lymphangitis.
CONCLUSION:
Conservative medical management of endometrial cancer in young women willing to preserve their reproductive potential, carries on potential risks. Careful selection of cases, informed consent, and strict follow up procedures are mandatory.
AuthorsG Ferrandina, G F Zannoni, V Gallotta, E Foti, S Mancuso, G Scambia
JournalGynecologic oncology (Gynecol Oncol) Vol. 99 Issue 1 Pg. 215-7 (Oct 2005) ISSN: 0090-8258 [Print] United States
PMID15979130 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dydrogesterone
Topics
  • Adult
  • Carcinoma, Endometrioid
  • Disease Progression
  • Dydrogesterone (therapeutic use)
  • Endometrial Neoplasms (diagnostic imaging, drug therapy, pathology)
  • Female
  • Humans
  • Hysteroscopy
  • Pregnancy
  • Pregnancy Complications, Neoplastic (diagnostic imaging, drug therapy, pathology)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: